AU5819800A - Cdna sequences of two interacting fancip2 and fancip3 of the fanconi anemia complementation group a protein - Google Patents
Cdna sequences of two interacting fancip2 and fancip3 of the fanconi anemia complementation group a proteinInfo
- Publication number
- AU5819800A AU5819800A AU58198/00A AU5819800A AU5819800A AU 5819800 A AU5819800 A AU 5819800A AU 58198/00 A AU58198/00 A AU 58198/00A AU 5819800 A AU5819800 A AU 5819800A AU 5819800 A AU5819800 A AU 5819800A
- Authority
- AU
- Australia
- Prior art keywords
- fancip3
- fancip2
- interacting
- protein
- cdna sequences
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000009095 Fanconi Anemia Complementation Group A protein Human genes 0.000 title 1
- 108010087740 Fanconi Anemia Complementation Group A protein Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Diabetes (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19929887 | 1999-06-29 | ||
| DE19929887A DE19929887A1 (en) | 1999-06-29 | 1999-06-29 | cDNA sequences of two interacors FANCIP2 and FANCIP3 of the Fanconi anemia protein of complementation group A. |
| PCT/EP2000/005878 WO2001000822A2 (en) | 1999-06-29 | 2000-06-26 | Cdna sequences of two interacting fancip2 and fancip3 of the fanconi anemia complementation group a protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU5819800A true AU5819800A (en) | 2001-01-31 |
Family
ID=7913003
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU58198/00A Abandoned AU5819800A (en) | 1999-06-29 | 2000-06-26 | Cdna sequences of two interacting fancip2 and fancip3 of the fanconi anemia complementation group a protein |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1194547A2 (en) |
| JP (1) | JP2003503053A (en) |
| AU (1) | AU5819800A (en) |
| DE (1) | DE19929887A1 (en) |
| WO (1) | WO2001000822A2 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5952190A (en) * | 1996-10-04 | 1999-09-14 | Fanconi Anemia Research Fund, Inc. | cDNA for fanconi anemia complementation group A |
| CA2284109A1 (en) * | 1997-03-19 | 1998-09-24 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
-
1999
- 1999-06-29 DE DE19929887A patent/DE19929887A1/en not_active Ceased
-
2000
- 2000-06-26 EP EP00943885A patent/EP1194547A2/en not_active Withdrawn
- 2000-06-26 WO PCT/EP2000/005878 patent/WO2001000822A2/en not_active Ceased
- 2000-06-26 AU AU58198/00A patent/AU5819800A/en not_active Abandoned
- 2000-06-26 JP JP2001506815A patent/JP2003503053A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001000822A2 (en) | 2001-01-04 |
| JP2003503053A (en) | 2003-01-28 |
| DE19929887A1 (en) | 2001-01-11 |
| WO2001000822A3 (en) | 2001-07-05 |
| EP1194547A2 (en) | 2002-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3725300A (en) | Interleukin 17 receptor-like protein | |
| AU6058500A (en) | Fusion protein and uses thereof | |
| AU1220001A (en) | Novel proteins and polynucleotides encoding them | |
| AU6045900A (en) | Interaction-activated proteins | |
| AU1608201A (en) | Human zven proteins | |
| AU6223700A (en) | Gtp-binding associated proteins | |
| AU4776800A (en) | Acetylcholinesterase-derived peptides and uses thereof | |
| AU4052200A (en) | Multidrug resistance associated proteins and uses thereof | |
| AU3609300A (en) | Human serpin proteins | |
| AU7508100A (en) | Human seizure related proteins | |
| AU1891301A (en) | Novel polypeptide and dna thereof | |
| AU7089800A (en) | 29 human cancer associated proteins | |
| AU6179600A (en) | Peptides and pharmaceutical compositions comprising same | |
| AU1389999A (en) | Bmog, a novel protein member of the myelin-oligodendrocyte glycoprotein family and its use for immunomodulatory purposes | |
| AU2136401A (en) | P450rai-2 and related proteins | |
| AU1574401A (en) | Granulocyte peptide homolog zgpa1 | |
| AU4197600A (en) | Eubacterial tmrna sequences and uses thereof | |
| AU2399601A (en) | Novel tachykinin-like polypeptides and use thereof | |
| AU5819800A (en) | Cdna sequences of two interacting fancip2 and fancip3 of the fanconi anemia complementation group a protein | |
| AU1881200A (en) | Novel proteins | |
| AU1540701A (en) | Novel protein | |
| AU2225401A (en) | Novel protein and dna thereof | |
| AU3362801A (en) | Cdna sequence of two interactors fancip4 and fancip5 of the fanconi anaemia proteins of the complementation groups a and | |
| AU2002500A (en) | Novel protein | |
| AU7304600A (en) | Novel protein |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |